文献速递皮肤肿瘤

瑞典实体器官移植受者皮肤癌风险分层与结局

Skin Cancer Risk Stratification and Outcomes in Swedish Solid Organ Transplant Recipients.
PubMed 文献 · J Invest Dermatol · 2026-09-22

该回顾性真实世界队列纳入瑞典卡罗林斯卡大学医院395例实体器官移植受者,按皮肤癌风险分为低、中、高危并随访2010至2023年。38.23%发生侵袭性皮肤癌,中危和高危者侵袭性皮肤癌风险分别为低危者的5.98倍和11.90倍,死亡风险亦升高。该模型有助于风险分层随访。

要点

  • 实体器官移植受者中38.23%发生侵袭性皮肤癌。
  • 中危和高危者侵袭性皮肤癌风险分别为低危者的5.98倍和11.90倍。
  • 中危和高危者死亡风险分别为低危者的1.53倍和1.97倍。

核心结论

  • 基于皮肤癌风险分层的随访模型可区分中危与低危实体器官移植受者的皮肤癌发生时间,并可能改善生存结局。

研究设计与样本

  • 回顾性真实世界队列研究,纳入瑞典卡罗林斯卡大学医院395例实体器官移植受者,2010年至2023年随访,按皮肤癌风险分为低、中、高危。

主要发现

  • 151例(38.23%)发生侵袭性皮肤癌。
  • 高危组(n=30)移植后首次侵袭性皮肤癌时间最短,其次为中危组(n=112)和低危组(n=253)(p<0.0001)。
  • 调整分析中,中危和高危组侵袭性皮肤癌风险分别为低危组的5.98倍(95%CI:4.05-8.34)和11.90倍(95%CI:7.02-20.19)。
  • 中危和高危组死亡风险分别为低危组的1.53倍(95%CI:1.03-2.27)和1.97倍(95%CI:1.10-3.54)。
  • 10例发生转移,4例死于皮肤癌。

临床怎么用

  • 该风险分层模型可作为实体器官移植受者随访的动态工具,用于皮肤癌二级预防和风险分层管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Solid organ transplant recipients (SOTRs) have an increased risk of cutaneous malignancies due to long-term immunosuppressive therapy. To evaluate a risk stratification model for follow-up of SOTRs at Karolinska University Hospital, Sweden, in which SOTRs are categorized based on skin cancer risk (low, intermediate, high), 395 patients were followed from 2010 until 2023 in this retrospective, real-world cohort. Over a third of SOTRs (n=151, 38.23%) developed invasive skin cancer. High-risk SOTRs (n=30) displayed the shortest time to first post-transplant invasive skin cancer, followed by intermediate- (n=112) and low-risk SOTRs (n=253) (p<0.0001). In adjusted analyses, intermediate- and high-risk SOTRs had 5.98-fold (95% confidence intervals (CI): 4.05-8.34) and 11.90-fold (95% CI: 7.02-20.19) higher hazard of invasive skin cancer compared to low-risk SOTRs, respectively. Intermediate- and high-risk SOTRs had 1.53-fold (95% CI: 1.03-2.27) and 1.97-fold (95% CI: 1.10-3.54) higher hazard of death compared to low-risk SOTRs. Ten patients developed metastasis and four died of skin cancer. This model serves as a dynamic tool for follow-up and provides time-to-skin-cancer discrimination between intermediate- and low-risk SOTRs. The findings illustrate the potential utility of risk-based stratification of SOTR follow-up and secondary prevention of cutaneous malignancies, potentially improving survival outcomes in this patient group.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Djalali A, Babačić H, Magnuson E, et al. Skin Cancer Risk Stratification and Outcomes in Swedish Solid Organ Transplant Recipients. J Invest Dermatol. 2026. PMID: 42772591. doi:10.1016/j.jid.2026.09.844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。